S.Antonyuk
et al.
(2010).
Structural discovery of small molecule binding sites in Cu-Zn human superoxide dismutase familial amyotrophic lateral sclerosis mutants provides insights for lead optimization.
J Med Chem,
53,
1402-1406.
PubMed id: 20067275
Structural discovery of small molecule binding sites in Cu-Zn human superoxide dismutase familial amyotrophic lateral sclerosis mutants provides insights for lead optimization.
S.Antonyuk,
R.W.Strange,
S.S.Hasnain.
ABSTRACT
Dominant inheritance of point mutations in CuZn superoxide dismutase (SOD1) is
the best characterized subset of familial amyotrophic lateral sclerosis (FALS)
and accounts for some 20% of the known familial cases. We report the discovery
and visualization via cocrystallography of two ligand-binding pockets in human
SOD1 and its pathogenic mutants that have opened up the real possibility of
undertaking lead compound discovery using a fragment-based approach for
therapeutic purposes for SOD1 associated motor neuron disease.
Literature references that cite this PDB file's key reference
M.Chruszcz,
M.Domagalski,
T.Osinski,
A.Wlodawer,
and
W.Minor
(2010).
Unmet challenges of structural genomics.
Curr Opin Struct Biol,
20,
587-597.
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.